Skip to content
WAY

Waystar Holding Corp.

Waystar Holding Corp. Q2 FY2025 earnings call

July 30, 2025 · fiscal period ended 2025-06

EPS · actual vs est

$0.36 / $0.33Beat +9.1%

Revenue · actual vs est

$270.7M / $256.1MBeat +5.7%
Ask about this call

Summary

Generated 2025-07-30

Management highlights

  • Announced acquisition of Iodine Software, a strategic fit for AI-powered clinical intelligence, expected to be accretive to margins and revenue growth. - Q2 saw 15% y-o-y revenue growth to $271 million with an adjusted EBITDA margin of 42%. - Strong demand for Waystar's AI-powered platform as providers seek efficient revenue cycle management. - Key innovations include insurance coverage detection, patient payment optimization, and reimbursement/cash flow solutions. - Net revenue retention rate is 115%, with 1,268 clients generating over $100,000 in trailing 12-month revenue.
View in transcript ↓

Segment performance

Revenue in Q2 reached $271 million, representing 15% year-over-year growth. Subscription revenue was $131 million, up 17% year-over-year, and volume-based revenue was $138 million, up 14% year-over-year. Provider solutions comprise approximately 70% of the total revenue.

View in transcript ↓

Guidance

  • Raised 2025 revenue guidance to a range of $1.30 billion to $1.42 billion (midpoint $1.36 billion), representing 10% y-o-y growth. - Raised adjusted EBITDA guidance to a range of $418 million to $426 million (midpoint $422 million). - Excludes impact of Iodine acquisition, which is expected to add subscription revenue and over $15 million in cost synergies within 2 years.
View in transcript ↓

Risks

  • Potential impact of legislative changes or funding reductions on specific payer types, but Waystar's diverse client base and solutions insulate from downside. - Competitive landscape and potential for competitors to regain lost clients.
View in transcript ↓

Q&A highlights

Q: In 1Q '25, you mentioned $10 million revenue boost from client migration, any benefit in 2Q?

A: The benefit had lapped by Q2 2025, so no notable difference.

Q: Rapid onboarding of large clients, is the volume-based revenue from them recurring?

A: Highly recurring, subscription revenue will follow as contract progresses.

Q: Impact of MCO earnings calls complaining about AI tools?

A: Waystar is insulated due to its diverse business model and solutions serving all payer types.

Q: Feedback on prior authorization pledge?

A: Early feedback is positive, with providers benefiting from streamlined authorization processes.

View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS$0.36$0.33+9.1%
Revenue$270.7M$256.1M+5.7%

Transcript

July 30, 2025

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.